Cargando…

Identification of CDC42 Effectors Operating in FGD1-Dependent Trafficking at the Golgi

Loss of function mutations in the FGD1 gene cause a rare X-linked disease, faciogenital dysplasia (FGDY, also known as Aarskog-Skott syndrome), which is associated with bone and urogenital abnormalities. The FGD1 gene encodes à CDC42-specific guanine nucleotide exchange factor. The mutations are fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Egorov, Mikhail, Polishchuk, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369352/
https://www.ncbi.nlm.nih.gov/pubmed/30778386
http://dx.doi.org/10.3389/fcell.2019.00007
_version_ 1783394167190192128
author Egorov, Mikhail
Polishchuk, Roman
author_facet Egorov, Mikhail
Polishchuk, Roman
author_sort Egorov, Mikhail
collection PubMed
description Loss of function mutations in the FGD1 gene cause a rare X-linked disease, faciogenital dysplasia (FGDY, also known as Aarskog-Skott syndrome), which is associated with bone and urogenital abnormalities. The FGD1 gene encodes à CDC42-specific guanine nucleotide exchange factor. The mutations are frequently located in the DH module of FGD1 preventing its transformation to the active form. We previously reported that Golgi-associated FGD1 regulates post-Golgi transport of some conventional and bone-specific proteins in a CDC42-dependent manner. However, the downstream targets of FGD1/CDC42 signaling that operate to support transport from the Golgi remain elusive. Here, we demonstrate that Golgi-localized CDC42 effectors might be involved in FGD1-mediated post-Golgi transport, probably through coordination of Golgi membrane and cytoskeleton dynamics. Overexpression of effector-specific CDC42 mutants (exhibiting preferential affinities for PAK1, IQGAP1, N-WASP, or PAR6) only partially rescue membrane trafficking in FGD1-deficient cells, indicating that the orchestrated activities of several downstream targets of CDC42 are required to support FGD1-mediated export from the Golgi. Our findings provide new insights into understanding the molecular mechanisms behind FGD1/CDC42-dependent transport events and uncover new targets whose potential might be explored for correction of membrane trafficking in FGDY.
format Online
Article
Text
id pubmed-6369352
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63693522019-02-18 Identification of CDC42 Effectors Operating in FGD1-Dependent Trafficking at the Golgi Egorov, Mikhail Polishchuk, Roman Front Cell Dev Biol Cell and Developmental Biology Loss of function mutations in the FGD1 gene cause a rare X-linked disease, faciogenital dysplasia (FGDY, also known as Aarskog-Skott syndrome), which is associated with bone and urogenital abnormalities. The FGD1 gene encodes à CDC42-specific guanine nucleotide exchange factor. The mutations are frequently located in the DH module of FGD1 preventing its transformation to the active form. We previously reported that Golgi-associated FGD1 regulates post-Golgi transport of some conventional and bone-specific proteins in a CDC42-dependent manner. However, the downstream targets of FGD1/CDC42 signaling that operate to support transport from the Golgi remain elusive. Here, we demonstrate that Golgi-localized CDC42 effectors might be involved in FGD1-mediated post-Golgi transport, probably through coordination of Golgi membrane and cytoskeleton dynamics. Overexpression of effector-specific CDC42 mutants (exhibiting preferential affinities for PAK1, IQGAP1, N-WASP, or PAR6) only partially rescue membrane trafficking in FGD1-deficient cells, indicating that the orchestrated activities of several downstream targets of CDC42 are required to support FGD1-mediated export from the Golgi. Our findings provide new insights into understanding the molecular mechanisms behind FGD1/CDC42-dependent transport events and uncover new targets whose potential might be explored for correction of membrane trafficking in FGDY. Frontiers Media S.A. 2019-02-04 /pmc/articles/PMC6369352/ /pubmed/30778386 http://dx.doi.org/10.3389/fcell.2019.00007 Text en Copyright © 2019 Egorov and Polishchuk. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Egorov, Mikhail
Polishchuk, Roman
Identification of CDC42 Effectors Operating in FGD1-Dependent Trafficking at the Golgi
title Identification of CDC42 Effectors Operating in FGD1-Dependent Trafficking at the Golgi
title_full Identification of CDC42 Effectors Operating in FGD1-Dependent Trafficking at the Golgi
title_fullStr Identification of CDC42 Effectors Operating in FGD1-Dependent Trafficking at the Golgi
title_full_unstemmed Identification of CDC42 Effectors Operating in FGD1-Dependent Trafficking at the Golgi
title_short Identification of CDC42 Effectors Operating in FGD1-Dependent Trafficking at the Golgi
title_sort identification of cdc42 effectors operating in fgd1-dependent trafficking at the golgi
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369352/
https://www.ncbi.nlm.nih.gov/pubmed/30778386
http://dx.doi.org/10.3389/fcell.2019.00007
work_keys_str_mv AT egorovmikhail identificationofcdc42effectorsoperatinginfgd1dependenttraffickingatthegolgi
AT polishchukroman identificationofcdc42effectorsoperatinginfgd1dependenttraffickingatthegolgi